Stockscreener 앱 받기
13.78
12.86%
1.57
전일 마감가:
$12.21
열려 있는:
$12.36
하루 거래량:
49,006
Relative Volume:
2.23
시가총액:
$81.55M
수익:
-
순이익/손실:
$-71.07M
주가수익비율:
-22.23
EPS:
-0.62
순현금흐름:
$-63.98M
1주 성능:
+52.60%
1개월 성능:
+73.54%
6개월 성능:
+31.16%
1년 성능:
+35.10%
1일 변동 폭
$12.36
$14.08
1주일 범위
$9.06
$14.53
52주 변동 폭
$4.2701
$21.43
바이케리어스 서지컬 Stock (RBOT) Company Profile
명칭
Vicarious Surgical Inc
전화
(617) 868-1700
주소
78 FOURTH AVENUE, WALTHAM
RBOT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
13.78 | 81.55M | 0 | -71.07M | -63.98M | -0.62 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
바이케리어스 서지컬 Stock (RBOT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | 개시 | Credit Suisse | Outperform |
| 2021-12-07 | 개시 | Cowen | Outperform |
| 2021-11-05 | 개시 | Canaccord Genuity | Buy |
| 2021-10-18 | 개시 | BTIG Research | Buy |
| 2021-10-07 | 개시 | Piper Sandler | Overweight |
모두보기
바이케리어스 서지컬 주식(RBOT)의 최신 뉴스
Vicarious Surgical CFO sells shares worth $976 - Investing.com India
Vicarious Surgical CEO Adam Sachs sells $7,327 in stock to cover taxes - Investing.com Nigeria
Vicarious surgical CTO Khalifa Sammy sells shares worth $5,855 By Investing.com - Investing.com Australia
Vicarious surgical CTO Khalifa Sammy sells shares worth $5,855 - Investing.com
Vicarious Surgical CFO sells shares worth $976 By Investing.com - Investing.com UK
Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely - Yahoo Finance
How To Trade (RBOT) - Stock Traders Daily
Vicarious Surgical says first surgical robot trials remain on track, analysts remain neutral - Mass Device
Earnings call: Vicarious Surgical reports narrowed Q3 loss, progress on tech - Investing.com
Vicarious Surgical stock target cut, keeps neutral rating on Q3 loss - Investing.com
Vicarious Surgical price target lowered to $10.50 from $12 at Piper Sandler - TipRanks
Vicarious Surgical Inc. (NYSE:RBOT) Q3 2024 Earnings Call Transcript - Insider Monkey
Vicarious Surgical operating expenses decrease 17% in Q3 2024 - Medical Buyer
Vicarious Surgical Inc. Reports Q3 2024 Financial Results - TipRanks
(RBOT) Proactive Strategies - Stock Traders Daily
Vicarious Surgical to Report Third Quarter 2024 Financial Results on November 12, 2024 - StockTitan
Vicarious Surgical Inc (RBOT) Q2 2024 Earnings Call Highlights: Strategic Partnerships and ... By GuruFocus - Investing.com Canada
Where are the Opportunities in (RBOT) - Stock Traders Daily
Vicarious Surgical CTO sells shares worth $644 to cover tax obligations - Investing.com India
Vicarious Surgical CEO sells shares worth $802 to cover tax obligations By Investing.com - Investing.com South Africa
Vicarious Surgical CFO sells shares to cover tax obligations - Investing.com
Vicarious Surgical CTO sells shares worth $644 to cover tax obligations By Investing.com - Investing.com South Africa
Vicarious Surgical CFO sells shares to cover tax obligations By Investing.com - Investing.com South Africa
Vicarious Surgical CEO sells shares worth $802 to cover tax obligations - Investing.com India
(RBOT) Trading Report - Stock Traders Daily
Vicarious Surgical CTO sells shares for tax obligations - Investing.com
Vicarious Surgical COO sells shares worth over $1,100 - Investing.com
Vicarious Surgical CEO sells shares worth over $2,300 - Investing.com India
Vicarious Surgical CEO sells shares worth over $2,300 By Investing.com - Investing.com Canada
Vicarious Surgical CTO sells shares for tax obligations By Investing.com - Investing.com Canada
ThredUp And 2 Other Penny Stocks Executives Are Buying - Benzinga
(RBOT) On The My Stocks Page - Stock Traders Daily
Short Interest in Vicarious Surgical Inc (NYSE:RBOT) Grows By 46.6% - Defense World
Vicarious Surgical Inc. (RBOT): Among The Best Medical AI Companies - Insider Monkey
Vicarious Surgical CTO sells shares worth over $3,500 By Investing.com - Investing.com Australia
Vicarious Surgical CTO sells shares worth over $3,500 - Investing.com India
Vicarious Surgical CEO sells shares worth over $4,400 - Investing.com India
Vicarious Surgical CEO sells shares worth over $4,400 By Investing.com - Investing.com Canada
Vicarious Surgical to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - Manchestertimes
Encision Signs Master Services Agreement with Vicarious Surgical Inc. - StockTitan
Vicarious Surgical (NYSE:RBOT) Price Target Cut to $12.00 by Analysts at Piper Sandler - Defense World
TD Cowen raises Vicarious stock on robotic system development updates - Investing.com
Vicarious Surgical stock target cut, retains neutral rating on Q2 results - Investing.com
바이케리어스 서지컬 (RBOT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.65%
자본화:
|
볼륨(24시간):